Rechte & Gesellschaft
EU Panel Recommends 12 New Medicines for Approval
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended twelve new medicines for marketing authorisation in the EU. The recommendations cover a range of treatments for various diseases, offering new options for patients and healthcare professionals. Following the CHMP's positive opinion, the European Commission will make the final decision on granting approval for these medicines across the Union. This marks a significant step in bringing new therapeutic innovations to the European market.
New treatments for several diseases are one step closer to being available in your country.